✦ LIBER ✦

Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy

✍ Scribed by Michael J. Zelefsky; Howard I. Scher; George Krol; Russell K. Portenoy; Steven A. Leibel; Zvi Y. Fuks

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 614 KB
Volume: 70
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19921101)70:9<2319::aid-cncr2820700918>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of complementary therapies on cl

Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer

✍ Clair Beard; William B. Stason; Qian Wang; Judith Manola; Elizabeth Dean-Clower; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

## Abstract ## BACKGROUND. This pilot randomized controlled trial (RCT) examined the clinical effects of 2 complementary (CAM) therapies, relaxation response therapy (RRT) and Reiki therapy, in men being treated with external beam radiotherapy (EBRx) for prostate cancer. ## METHODS. Study partic

Novel concept of antisurvival factor (AS

Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: Case report

✍ Koutsilieris, Michael; Tzanela, Marinella; Dimopoulos, Theodoros 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## BACKGROUND. Osteoblasts and osteoblast-derived survival growth factors, such as insulin-like growth factor I (IGF I), inhibit chemotherapy apoptosis of prostate cancer cells, thereby producing cytotoxic drug-resistant tumor growth, in vitro. METHODS. We tested a novel therapeutic approach, refe

Pretreatment frequency of circulating IL

Pretreatment frequency of circulating IL-17+CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients

✍ Evelyna Derhovanessian; Victoria Adams; Karin Hähnel; Andrea Groeger; Hardev Pan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 275 KB 👁 1 views

## Abstract The aim of this study was to determine the prognostic implications of the pretreatment level of Th17 cells compared with regulatory T‐cell status in prostate cancer patients receiving active whole cell immunotherapy. Ten‐color flow cytometry was used to analyze IL‐17‐producing CD4^+^ T‐

Phosphorylation of ERK1/2 mitogen-activa

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

✍ Julia M.W. Gee; John F.R. Robertson; Ian O. Ellis; Robert I. Nicholson 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 207 KB 👁 2 views

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views